Practice
Open Access
Polio
Aoife M.R. Pucchio, Anwar Alabdulraheem and Marina I. Salvadori
CMAJ November 15, 2022 194 (44) E1509; DOI: https://doi.org/10.1503/cmaj.221320
Aoife M.R. Pucchio
Faculty of Social Science (Pucchio), University of Western Ontario, London, Ont.; Department of Pediatrics (Alabdulraheem, Salvadori), Faculty of Medicine, McGill University, Montréal, Que.; Public Health Agency of Canada (Salvadori), Ottawa, Ont.
Anwar Alabdulraheem
Faculty of Social Science (Pucchio), University of Western Ontario, London, Ont.; Department of Pediatrics (Alabdulraheem, Salvadori), Faculty of Medicine, McGill University, Montréal, Que.; Public Health Agency of Canada (Salvadori), Ottawa, Ont.
Marina I. Salvadori
Faculty of Social Science (Pucchio), University of Western Ontario, London, Ont.; Department of Pediatrics (Alabdulraheem, Salvadori), Faculty of Medicine, McGill University, Montréal, Que.; Public Health Agency of Canada (Salvadori), Ottawa, Ont.
In this issue
Article extras
Article tools
Polio
Aoife M.R. Pucchio, Anwar Alabdulraheem, Marina I. Salvadori
CMAJ Nov 2022, 194 (44) E1509; DOI: 10.1503/cmaj.221320
Jump to section
- Article
- Oral polio vaccine is used internationally, but not in Canada since 1996
- Polio virus could be circulating in Canada
- Underimmunized people (< 4 doses of a polio vaccine) are at risk of poliovirus infection
- Clinical presentation of poliovirus infection ranges from subclinical to paralysis and death4
- Polio should be considered in all patients with acute flaccid paralysis
- Footnotes
- References
- Responses
- Metrics
Related Articles
Cited By...
- No citing articles found.